人工血管の世界市場:製品別(血液透析用人工血管、動脈瘤修復用人工血管、人工抹消血管)、素材別(ポリエステル、ポリテトラフルオロエチレン(PTFE)、ポリウレタン、生合成)、エンドユーザー別(病院・通院外科診療所(ASC))

【英語タイトル】Vascular Graft Market by Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), by Raw Material (Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, and Biosynthetic), and by End-User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Allied Market Researchが出版した調査資料(AMR8040348)・商品コード:AMR8040348
・発行会社(調査会社):Allied Market Research
・発行日:2017年8月
・ページ数:150
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:Medical Devices & Supplies
◆販売価格オプション(消費税別)
Single UserUSD5,540 ⇒換算¥592,780見積依頼/購入/質問フォーム
5 UserUSD6,903 ⇒換算¥738,621見積依頼/購入/質問フォーム
Enterprise UserUSD7,734 ⇒換算¥827,538見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本資料は、人工血管の世界市場について調べ、人工血管の世界規模、市場動向、市場環境、製品別(血液透析用人工血管、動脈瘤修復用人工血管、人工抹消血管)分析、素材別(ポリエステル、ポリテトラフルオロエチレン(PTFE)、ポリウレタン、生合成)分析、エンドユーザー別(病院・通院外科診療所(ASC))分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・人工血管の世界市場概要
・人工血管の世界市場環境
・人工血管の世界市場動向
・人工血管の世界市場規模
・人工血管の世界市場:製品別(血液透析用人工血管、動脈瘤修復用人工血管、人工抹消血管)
・人工血管の世界市場:素材別(ポリエステル、ポリテトラフルオロエチレン(PTFE)、ポリウレタン、生合成)
・人工血管の世界市場:エンドユーザー別(病院・通院外科診療所(ASC))
・人工血管の世界市場:地域別市場規模・分析
・人工血管の北米市場規模・予測
・人工血管のアメリカ市場規模・予測
・人工血管のヨーロッパ市場規模・予測
・人工血管のアジア市場規模・予測
・人工血管の日本市場規模・予測
・人工血管の中国市場規模・予測
・関連企業情報
【レポートの概要】

A vascular graft is a medical device that acts as an artificial blood vessel. It is implanted in patients with blocked blood vessels to redirect the flow of blood from one organ to the other to restore the normal flow of blood within the body.

The global vascular graft market is driven by increase in the incidence of vascular disorders, high blood glucose level, hypertension, and other risk factors that cause blockage of blood vessels. The global vascular grafts market was valued at $4,192 million in 2016, and is expected to reach at $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. In addition, sedentary lifestyle, rise in geriatric population, and technological advancements supplement the market growth. However, high cost of treatment and increase in complications associated with prosthetic grafts restrain the market growth. Conversely, rise in awareness for vascular grafts and huge market opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities to the market players in the near future.

The global vascular graft market is segmented on the basis of product, raw material, end user, and region. On the basis of product, it is classified into endovascular stent graft, peripheral vascular graft, and hemodialysis access graft. The endovascular stent graft segment is bifurcated into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of raw material, it is categorized into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. Based on end user, it is divided into hospitals & ambulatory surgical centers. The market is analyzed based on region into North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Comprehensive analyses of the product type and raw materials help in understanding the regional trends and potential investment areas.
Key market players and their strategies have been thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

Hemodialysis Access Graft
Endovascular Aneurysm Repair Stent Grafts
Abdominal Aortic Aneurysm (AAA)
Thoracic Aortic Aneurysm (TAA)
Peripheral Vascular Graft

By Raw Material

Polytetrafluoroethylene (PTFE)
Polyurethane (PU)
Polyester
Biosynthetic

By End User

Hospitals
Ambulatory Surgical Centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA

List of key players profiled in the report

B. Braun Melsungen AG
C. R. Bard Inc.
Cardinal Health Inc.
Cook Medical Inc.
Endologix Inc.
LeMaitre Vascular Inc.
MAQUET Holding B.V. & Co. KG (a Getinge Group Company)
Medtronic plc.
Terumo Corporation
W. L. Gore & Associates Inc.

List of the other players in the value chain (these players are not profiled in the report, the same can be included on request)

Cardiatis SA
JOTEC GmbH
Lombard Medical Inc.
Japan Lifeline Co. Ltd.
Nano Endoluminal

【レポートの目次】

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. TOP PLAYER POSITIONING, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rise in incidence of risk factors that lead to blockage of blood vessels
3.4.1.2. Increase in geriatric population
3.4.1.3. Technological advancements
3.4.1.4. Lifestyle changes leading to blockage of blood vessels

3.4.2. Restraints

3.4.2.1. High cost of treatment
3.4.2.2. Complications associated with prosthetic grafts

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increase in awareness for vascular grafts

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL VASCULAR GRAFT MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. HEMODIALYSIS ACCESS GRAFT

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS

4.3.1. Abdominal Aortic Aneurysm (AAA)
4.3.2. Thoracic Aortic Aneurysm (TAA)
4.3.3. Key market trends
4.3.4. Key growth factors and opportunities
4.3.5. Market size and forecast

4.4. PERIPHERAL VASCULAR GRAFT

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 VASCULAR GRAFT MARKET, BY RAW MATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. POLYESTER

5.2.1. Market size and forecast

5.3. POLYTETRAFLUOROETHYLENE (PTFE)

5.3.1. Market size and forecast

5.4. POLYURETHANE

5.4.1. Market size and forecast

5.5. BIOSYNTHETIC

5.5.1. Market size and forecast

CHAPTER 6 VASCULAR GRAFT MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

CHAPTER 7 VASCULAR GRAFT MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA

CHAPTER 8 COMPANY PROFILES

8.1. B. BRAUN MELSUNGEN AG

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.8. Key strategic moves and developments

8.2. C. R. BARD, INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments

8.3. CARDINAL HEALTH INC.

8.3.1. Company overview
8.3.2. Company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.8. Key strategic moves and developments

8.4. COOK MEDICAL INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments

8.5. ENDOLOGIX INC.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.8. Key strategic moves and developments

8.6. LEMAITRE VASCULAR, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.8. Key strategic moves and developments

8.7. MAQUET HOLDING B.V. & CO. KG

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments

8.8. MEDTRONIC PLC

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments

8.9. TERUMO CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating product categories
8.9.4. Product portfolio
8.9.5. Business performance
8.9.8. Key strategic moves and developments

8.10. W. L. GORE & ASSOCIATES, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio

TABLE 1. GLOBAL VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. PERIPHERAL VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 7. VASCULAR GRAFTS MARKET FOR POLYESTER, BY REGION, 2016-2023 ($MILLION)
TABLE 8. VASCULAR GRAFTS MARKET FOR PTFE, BY REGION, 2016-2023 ($MILLION)
TABLE 9. VASCULAR GRAFTS MARKET FOR POLYURETHANE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. VASCULAR GRAFTS MARKET FOR BIOSYNTHETIC, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 12. VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. VASCULAR GRAFTS MARKET FOR ASCS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. EUROPE VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 22. EUROPE VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. LAMEA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. LAMEA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. LAMEA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 30. LAMEA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 32. B. BRAUN MELSUNGEN AG: OPERATING BUSINESS SEGMENTS
TABLE 33. C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 34. C. R. BARD, INC.: OPERATING BUSINESS SEGMENTS
TABLE 35. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 36. CARDINAL HEALTH INC.: OPERATING BUSINESS SEGMENTS
TABLE 37. COOK MEDICAL INC.: COMPANY SNAPSHOT
TABLE 38. COOK MEDICAL INC.: PRODUCT CATEGORIES
TABLE 39. ENDOLOGIX INC.: COMPANY SNAPSHOT
TABLE 40. ENDOLOGIX INC.: OPERATING BUSINESS SEGMENTS
TABLE 41. LEMAITRE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 42. LEMAITRE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 43. MAQUET HOLDING B.V. & CO. KG: COMPANY SNAPSHOT
TABLE 44. MAQUET HOLDING B.V. & CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 45. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 46. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 47. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 48. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 49. W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 50. W. L. GORE & ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS

FIGURE 1. VASCULAR GRAFT MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, VASCULAR GRAFT MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: VASCULAR GRAFT MARKET
FIGURE 10. GEOGRAPHICAL DISTRIBUTION OF COMPLETED CLINICAL TRIALS IN VASCULAR GRAFT MARKET (%)
FIGURE 11. U.S. VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 12. CANADA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 13. MEXICO VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 14. GERMANY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 15. FRANCE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 16. UK VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 17. ITALY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 18. SPAIN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 19. REST OF EUROPE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 20. JAPAN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 21. CHINA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 22. INDIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 23. SOUTH KOREA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 24. AUSTRALIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 25. REST OF ASIA-PACIFIC VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 26. BRAZIL VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 27. SOUTH AFRICA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 28. SAUDI ARABIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 29. REST OF LAMEA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 30. B. BRAUN MELSUNGEN AG: FINANCIALS, 2014-2016 ($MILLION)

★調査レポート[人工血管の世界市場:製品別(血液透析用人工血管、動脈瘤修復用人工血管、人工抹消血管)、素材別(ポリエステル、ポリテトラフルオロエチレン(PTFE)、ポリウレタン、生合成)、エンドユーザー別(病院・通院外科診療所(ASC))] (コード:AMR8040348)販売に関する免責事項を必ずご確認ください。
★調査レポート[人工血管の世界市場:製品別(血液透析用人工血管、動脈瘤修復用人工血管、人工抹消血管)、素材別(ポリエステル、ポリテトラフルオロエチレン(PTFE)、ポリウレタン、生合成)、エンドユーザー別(病院・通院外科診療所(ASC))]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆